Free Trial

IRIDEX (IRIX) Competitors

IRIDEX logo
$1.02 0.00 (0.00%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$1.02 +0.00 (+0.10%)
As of 05/21/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRIX vs. FONR, SRTS, MLSS, INO, NTRB, ZYXI, VANI, OM, HYPR, and SURG

Should you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include FONAR (FONR), Sensus Healthcare (SRTS), Milestone Scientific (MLSS), Inovio Pharmaceuticals (INO), Nutriband (NTRB), Zynex (ZYXI), Vivani Medical (VANI), Outset Medical (OM), Hyperfine (HYPR), and SurgePays (SURG). These companies are all part of the "medical equipment" industry.

IRIDEX vs.

FONAR (NASDAQ:FONR) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment, valuation and community ranking.

50.6% of FONAR shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 1.6% of FONAR shares are owned by insiders. Comparatively, 7.3% of IRIDEX shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

IRIDEX received 91 more outperform votes than FONAR when rated by MarketBeat users. However, 74.79% of users gave FONAR an outperform vote while only 62.10% of users gave IRIDEX an outperform vote.

CompanyUnderperformOutperform
FONAROutperform Votes
181
74.79%
Underperform Votes
61
25.21%
IRIDEXOutperform Votes
272
62.10%
Underperform Votes
166
37.90%

FONAR has a net margin of 7.68% compared to IRIDEX's net margin of -22.79%. FONAR's return on equity of 4.94% beat IRIDEX's return on equity.

Company Net Margins Return on Equity Return on Assets
FONAR7.68% 4.94% 3.70%
IRIDEX -22.79%-192.95%-33.97%

FONAR has higher revenue and earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FONAR$103.02M0.82$10.57M$1.2510.96
IRIDEX$48.67M0.35-$9.57M-$0.43-2.37

FONAR has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, IRIDEX has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500.

In the previous week, IRIDEX had 1 more articles in the media than FONAR. MarketBeat recorded 3 mentions for IRIDEX and 2 mentions for FONAR. FONAR's average media sentiment score of 0.42 beat IRIDEX's score of 0.33 indicating that FONAR is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FONAR
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IRIDEX
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

FONAR beats IRIDEX on 12 of the 15 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRIX vs. The Competition

MetricIRIDEXElectromedical equipment IndustryComputer SectorNASDAQ Exchange
Market Cap$17.13M$3.26B$25.09B$8.39B
Dividend YieldN/A1.73%2.90%4.10%
P/E Ratio-1.5216.6044.5919.71
Price / Sales0.3585.432,088.05117.39
Price / CashN/A44.0934.7834.62
Price / Book1.733.736.654.50
Net Income-$9.57M$94.03M$739.99M$248.18M
7 Day Performance2.00%0.75%-0.91%0.20%
1 Month Performance-6.42%20.87%12.61%12.37%
1 Year Performance-60.62%-12.91%52,628.86%7.04%

IRIDEX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRIX
IRIDEX
0.8078 of 5 stars
$1.02
flat
N/A-62.1%$17.13M$48.67M-1.52120Analyst Forecast
FONR
FONAR
1.7871 of 5 stars
$12.37
-0.2%
N/A-4.9%$76.83M$101.57M10.76480News Coverage
Positive News
Earnings Report
Analyst Upgrade
SRTS
Sensus Healthcare
2.7072 of 5 stars
$4.55
+1.3%
$13.00
+185.7%
-20.7%$75.05M$41.81M11.3840News Coverage
Earnings Report
Analyst Forecast
Analyst Revision
MLSS
Milestone Scientific
1.1407 of 5 stars
$0.93
-2.6%
$1.25
+35.1%
+26.5%$72.52M$8.63M-13.2230
INO
Inovio Pharmaceuticals
3.6613 of 5 stars
$1.94
+7.8%
$12.20
+528.9%
-82.0%$71.15M$217,756.00-0.49320Gap Up
NTRB
Nutriband
2.1833 of 5 stars
$5.83
+1.9%
$13.00
+123.0%
+9.2%$65.03M$2.14M-8.2110Positive News
ZYXI
Zynex
3.0267 of 5 stars
$2.15
+3.9%
$6.00
+179.1%
-78.5%$65.01M$172.40M14.33770Gap Down
VANI
Vivani Medical
3.1262 of 5 stars
$1.03
-1.0%
$4.00
+288.3%
-36.7%$61.02MN/A-2.2920News Coverage
Analyst Forecast
OM
Outset Medical
1.3617 of 5 stars
$16.29
+6.5%
$24.67
+51.4%
-66.3%$58.56M$113.69M-6.57520Analyst Forecast
Gap Down
High Trading Volume
HYPR
Hyperfine
3.5015 of 5 stars
$0.73
-1.9%
$1.33
+82.2%
-33.5%$56.82M$12.89M-1.28190Analyst Revision
Gap Up
SURG
SurgePays
2.8404 of 5 stars
$2.70
-3.6%
$8.75
+224.1%
-22.4%$55.11M$60.88M-2.3940

Related Companies and Tools


This page (NASDAQ:IRIX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners